Tender reference number
17/PN/2025/MT
Description
1.Subject of the order: Delivery of medicines for non-commercial clinical trial NINTOC-TU. Project financed by the Medical Research Agency (Co-financing agreement No 2022/ABM/01/00004. 2.Detailed description of the subject-matter of the contract is contained in the present SWZ and: 1) Annex 1 – Tender form; 2) Annex No. 2 – assortment and price form for Part No. 1-2, respectively; 3) Annex 3 – draft contract. 3.The Ordering Party shall allow partial tenders to be submitted. 4.The Contractor may submit a tender for all lots (packages) of the contract. The Contracting Authority shall not limit the number of lots for which the Contractor may submit a tender and shall not set a maximum number of lots for which a contract may be awarded to one Contractor. 5.Number of lots (packages, tasks): 2. 6.Place of execution of the order: medicines (parts 1-2) will be delivered to designated centres in Poland (i.e. 1. National Institute of Geriatrics, Rheumatology and Rehabilitation prof. dr hab. med. Eleonora Reicher Ul. Spartańska 1, 02-637 Warsaw Principal Investigator: Dr n.med. Maria Maślińska, 2. Department of Rheumatology, Medical University of Lodz, ul. Excursion 66, 91-518 Łódź Main researcher: dr n. med. Joanna Makowska, 3. University Clinical Hospital No. 1 im Norberta Barlickiego Medical University of Łódź Kopcińskiego 22, 90-153 Łódź Wojciech Piotrowski). The destination places of delivery will be indicated each time by the Ordering Party in the quantity and type specified by the Ordering Party within 5 working days from the date of placing the order in Poland. 7.Period of performance of the contract (for lots 1 and 2): 24 months from the date of conclusion of the contract. 8.Detailed issues regarding the date of performance of the contract are specified in the draft contract, constituting Annex 3 to the SWZ. 9.In the cases specified in the draft contract, the date of performance of the contract may be changed. Medications that are the subject of the contract must be authorised for marketing and use in the Republic of Poland. 11.The delivered assortment must be new and have at least a 12-month period of fitness for use counted from the date of its delivery to the Ordering Party. Each delivery of a medicinal product with a shorter expiry date must be preceded by an e-mail consent of the Ordering Party. 12.Marking of delivered products, instructions for use, product description, labels (original) must be prepared in Polish. 13.Transportation of investigational medicinal products under controlled conditions (according to the SmPC). 14.The subject of the order does not include the collection of unused medicine packages and their disposal. 15.The Contractor at his own expense will provide appropriate transport packaging and temperature monitoring during transport and will provide temperature reading reports with each delivery. 16.The transport of investigational medicinal products must meet the applicable requirements of the Study financed by the Medical Research Agency and national and European regulations, in particular: 1)Pharmaceutical law (i.e. Journal of Laws 2024, item 686, as amended); 2) Regulation of the Minister of Health of 13 March 2015 on the requirements of Good Distribution Practice (GDP) (i.e. Journal of Laws 20022, item 1287); 3)ISO 9001, 14001 standards; 4) European Certificate of Good Distribution Practice (EU GDP). 17.Along with the ordered medicine, each time the Contractor receives the medicine, he will provide a document about the conditions of transport. 18.All requirements specified in the SWZ and documents indicated above are minimum requirements, and their fulfillment is mandatory. Failure to meet the above-mentioned minimum requirements will result in the rejection of the tender as inconsistent with the terms of the contract pursuant to Art. 1 point 5 of the Public Procurement Act. 19.The Ordering Party does not allow the possibility of submitting variant offers. 20.The Contracting Authority does not provide for the award of contracts referred to in Art. 1 point 8 of the Public Procurement Act. 21.The Ordering Party does not provide for the exercise of the right of option. 22.In accordance with Article 257 of the Public Procurement Law, the Contracting Authority provides for the possibility of cancelling the procedure in question if the public funds that the Contracting Authority intended to allocate to finance all or part of the contract have not been awarded to it.
Text automatically translated in your browsing language
Automatically translated
Submission Method
Electronic via:
https://nigrr.ezamawiajacy.pl/
Tenders may be submitted
Electronic submission: required
https://nigrr.ezamawiajacy.pl/
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
30/06/2025 11:00
